Please complete the CAPTCHA to continue
@9meters.com
✓
1 phone found area 415
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Matthew Bryant is listed as Vice President, Medical Affairs | Clinical Development at Boston Pharmaceuticals, based in Palo Alto, California, United States. AeroLeads shows a work email signal at 9meters.com, phone signal with area code 415, and a matched LinkedIn profile for Matthew Bryant.
Matthew Bryant previously worked as Vice President, Medical Affairs at Boston Pharmaceuticals and Advisor (Volunteer) at Spark At Stanford. Matthew Bryant holds Doctor Of Pharmacy (Pharmd), Pharmacy from University Of California, San Francisco.
This section adds company-level context without repeating Matthew Bryant's masked contact details.
AeroLeads found 1 current-domain work email signal for Matthew Bryant. Compare company email patterns before reaching out.
As a biotech executive and a licensed pharmacist with over 20 years of experience in the biopharmaceutical industry, I have a passion for advancing medical affairs and clinical development in support of patients with rare and unmet medical needs. I have launched more than 12 new drugs across various therapeutic areas, collaborated with cross-functional teams to establish timely, data-driven medical narratives that supported FDA and EMA regulatory approvals and commercialization of novel therapies that improved patient lives, and led the expansion of global medical affairs departments and teams.Currently, I am an advisor (volunteer) at SPARK at Stanford University, where I mentor and guide academic researchers and innovators in translating their discoveries into new treatments and diagnostics for patients. I leverage my expertise in medical affairs, clinical development, orphan drugs, stakeholder engagement, patient advocacy, evidence-based medicine, health economics and outcomes research, real-world evidence, new drug launches, and business development to help them navigate the complex and competitive biopharmaceutical landscape and achieve their goals. I am also an active contributor to the scientific community, with multiple publications in peer-reviewed journals and presentations at medical conferences. I am always eager to learn new skills, share best practices, and collaborate with other professionals who share my vision and mission of improving healthcare outcomes and quality of life for patients.
Listed skills include Pharmaceutical Industry, Medical Affairs, Clinical Trials, Managed Care, and 42 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Cambridge, Ma, Us
Clinical trials: MASH (formerly NASH) liver disease (BOS-580, FGF21), HCC hepatocellular carcinoma (liver cancer) (BOS-342, 4IBB/GPC3 immuno-oncology antibody-anticalin bispecific protein)
Stanford, Ca, Us
Volunteer position acting as an pharmaceutical industry advisor to provide invaluable mentoring and support to SPARK scholars and awardees.
Clinical trials: Rare Short Bowel Syndrome (vurolenatide, GLP-1), Gastroenterology Celiac disease, Infectious diseases MIS-C (larazotide), Endocrinology Metabolic Obesity (GIP)
Products: Rare pediatric Hutchinson-Gilford Progeria Syndrome (Zokinvy)Clinical Trials: Infectious diseases, Hepatitis delta virus HDV (lonafarnib/ritonavir, peginterferon lambda), SARS-CoV-2 COVID-19 (peginterferon lambda), Endocrinology post-bariatric hypoglycemia and congenital hyperinsulinemia (avexitide, GLP-1 antagonist)
Leverkusen, North Rhine-Westphalia, De
Products: Oncology, Prostate Cancer, Rare Gene Solid Tumors, Colorectal Cancer, HCC, GIST (NUBEQA, VITRAKVI, Xofigo, Stivarga, Nexavar), Hemophilia (Kovaltry, Kogenate, JIVI), Women's Healthcare (Mirena, Kyleena, Skyla), Pulmonary PAH (Adempas), Hypertension (Adalat)Clinical Trials: Cardiovascular (Kerendia/finerenone)
South San Francisco, Ca, Us
Products: Infectious disease (VIBATIV), Pulmonary COPD (Yupelri)Clinical Trials: Gastroenterology IBD (velusetrag, JAK inhibitor), Cardiovascular, Neurogenic Orthostatic Hypotension (neprilysin inhibitor, NSRI)
Bridgewater, N.J, Us
Products and Clinical Trials: Hepatology (Xifaxan), GI IBS IBD Colorectal Cancer (Uceris, Apriso, Colazal, Giazo, Relistor, Moviprep, Osmoprep, Zegerid, Metozolv, Fulyzaq, Solesta), Endocrinology Diabetes (Glumetza, Cycloset), Pediatric Urology (Deflux), Rare Hereditary Angioedema (Ruconest), Infectious diseases
Products: Hepatology HCV (Infergen, Actimmune), Pulmonary Rare AAT deficiency (Aralast)Clinical Trials: Infectious diseases (oritavancin), IPF (Actimmune, Esbriet/pirfenidone)
Oakland, California, Us
ASHP/AMCP accredited Specialty Residency in Managed Care Pharmacy
Quick answers generated from the profile data available on this page.
Matthew Bryant works for Boston Pharmaceuticals.
Matthew Bryant is listed as Vice President, Medical Affairs | Clinical Development at Boston Pharmaceuticals.
AeroLeads has found 1 work email signal at @9meters.com for Matthew Bryant at Boston Pharmaceuticals.
AeroLeads has found 1 phone signal(s) with area code 415 for Matthew Bryant at Boston Pharmaceuticals.
Matthew Bryant is based in Palo Alto, California, United States while working with Boston Pharmaceuticals.
Matthew Bryant has worked for Boston Pharmaceuticals, Spark At Stanford, 9 Meters Biopharma, Inc., Eiger Biopharmaceuticals, Inc., and Bayer.
You can use AeroLeads to view verified contact signals for Matthew Bryant at Boston Pharmaceuticals, including work email, phone, and LinkedIn data when available.
Matthew Bryant holds Doctor Of Pharmacy (Pharmd), Pharmacy from University Of California, San Francisco.
Matthew Bryant is listed with skills including Pharmaceutical Industry, Medical Affairs, Clinical Trials, Managed Care, Gastroenterology, Healthcare, Clinical Research, and Biotechnology.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts